Cargando…

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin

BACKGROUND: Fecal biomarkers have emerged as one of the most useful tools for clinical management of inflammatory bowel disease (IBD). Oncostatin M (OSM), like fecal calprotectin (FC), is highly expressed in the inflamed intestinal mucosa which may have potential usefulness. We aimed to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Ying, Dai, Yibei, Zhang, Lingyu, Wang, Danhua, Hu, Wen, Yu, Qiao, Wang, Xuchu, Yu, Pan, Liu, Weiwei, Ping, Ying, Sun, Tao, Sang, Yiwen, Liu, Zhenping, Chen, Yan, Tao, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647726/ https://www.ncbi.nlm.nih.gov/pubmed/34880643 http://dx.doi.org/10.2147/JIR.S342846

Ejemplares similares

Prostatic aspirated cellular RNA analysis enables fast diagnosis and staging of prostate cancer
por: Sang, Yiwen, et al.
Publicado: (2020)

A Multivariate Diagnostic Model Based on Urinary EpCAM-CD9-Positive Extracellular Vesicles for Prostate Cancer Diagnosis
por: Dai, Yibei, et al.
Publicado: (2021)

Machine Learning Reveals a Multipredictor Nomogram for Diagnosing the Alzheimer’s Disease Based on Chemiluminescence Immunoassay for Total Tau in Plasma
por: Zhang, Lingyu, et al.
Publicado: (2022)

Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate Adenocarcinoma
por: Zhang, Lingyu, et al.
Publicado: (2021)

Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
por: Zhang, Lingyu, et al.
Publicado: (2021)

Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients
por: Sun, Tao, et al.
Publicado: (2019)

A quantitative detection of Cardiotrophin‐1 in chronic heart failure by chemiluminescence immunoassay
por: Ping, Ying, et al.
Publicado: (2021)

Emerging roles and mechanisms of microRNA-222-3p in human cancer (Review)
por: Wang, Danhua, et al.
Publicado: (2021)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway
por: Liu, Weiwei, et al.
Publicado: (2017)

SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
por: Liu, Weiwei, et al.
Publicado: (2018)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

A98 FECAL LEUKOCYTE ESTERASE: AN ALTERNATIVE BIOMARKER TO FECAL CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE
por: Klemm, N K, et al.
Publicado: (2022)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
por: Lee, Yang Woon, et al.
Publicado: (2019)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Comprehensive analysis of fifteen hub genes to identify a promising diagnostic model, regulated networks, and immune cell infiltration in acute kidney injury
por: Sun, Tao, et al.
Publicado: (2022)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease
por: Osredkar, Joško, et al.
Publicado: (2021)

Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
por: Romero-Mascarell, Cristina, et al.
Publicado: (2022)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
por: Jang, Hui Won, et al.
Publicado: (2016)

Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017)

From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
por: Mumolo, Maria Gloria, et al.
Publicado: (2018)

Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization
por: Fukunaga, Shuhei, et al.
Publicado: (2018)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
por: Crawford, Erin, et al.
Publicado: (2021)

Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
por: Han, Liang, et al.
Publicado: (2023)

Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration-Resistant Prostate Cancer
por: Yu, Pan, et al.
Publicado: (2022)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
por: Klingberg, Eva, et al.
Publicado: (2017)

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
por: Wei, Shu Chen
Publicado: (2016)

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017)

Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
por: Ho, Shaun S. C., et al.
Publicado: (2021)

Optimal Cutoff Level of Fecal Calprotectin for Detecting Small Bowel Inflammation in Crohn’s Disease
por: Kim, Eun Soo
Publicado: (2021)

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases
por: D'Amico, Ferdinando, et al.
Publicado: (2021)

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico
por: Maldonado-Arriaga, Brenda, et al.
Publicado: (2021)

The role of fecal calprotectin in pediatric disease
por: Jeong, Su Jin
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9ooo1hin8c8tl0ef7tmum5o367